Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. - Ogbogu PU; Roufosse F; Akuthota P; Kuna P; Groh M; Reiter A; Yokota A; Siddiqui SH; Mutsaers PGNJ; Li B; Khoury P; Bahadori LM; et al. (Nature medicine, 2026)